Plain-English translation of NCT06076538 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether a special imaging technique called PET/MR can help doctors better understand kidney masses that are found unexpectedly on imaging. Right now, doctors struggle to tell the difference between benign (harmless) kidney tumors and dangerous cancers, which sometimes leads to unnecessary surgery. This study hopes the advanced imaging will give clearer answers.
Many small kidney masses are found by accident on imaging scans, but doctors cannot always tell if they are harmless or cancer. This uncertainty often leads to surgery or other treatments that patients may not actually need. This study exists to develop better imaging tools that can accurately identify which tumors are truly dangerous and which ones can be safely monitored without treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive a PET/MR imaging scan — an advanced combination imaging test that takes pictures of your kidney mass. Your doctors will then manage your care following standard recommendations based on what the imaging shows. The study is observational, meaning researchers are watching and learning from the imaging results, not giving you any new medication or experimental treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States